FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311579647> ?p ?o ?g. }

• W4311579647 abstract "This study aimed to compare the survival outcome of 3 different treatment groups (arterial interventional chemotherapy or intravenous chemotherapy or concurrent chemoradiotherapy) for locally advanced cervical cancer.A total of 187 patients with pathological stage IB3-IIB cervical cancer (cervical squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma) hospitalized in the First Affiliated Hospital of Zhengzhou University from January 2013 to May 2019 were included. Therefore, this article is a retrospective study. We collected data from all eligible patients. And all according to the treatment methods at that time, they were divided into three subgroups: (1) 40 patients who received neoadjuvant arterial interventional chemotherapy + surgery + postoperative chemotherapy (IA-NAC + RS), (2) 63 patients who received neoadjuvant intravenous chemotherapy + surgery + postoperative chemotherapy (IV-NAC + RS), (3) 84 patients who only received concurrent chemoradiotherapy (CCRT). Notably, 108 of these patients met the 5-year follow-up period, and 187 patients met the 3-year follow-up period only. Consequently, we compared 5-year survival and 3-year survival separately. The prognosis (5-year survival and 3-year survival) of the three groups and the chemotherapy efficacy, intraoperative blood loss, operation time, and postoperative pathological risk factors of different subgroups were compared.(1) There were no significant differences in the 3-year overall survival (OS) rate, 3-year progression-free survival (PFS) rate, 5-year OS rate, and 5-year PFS rate among the three subgroups (p > 0.05). (2) The chemotherapy response rates of IA-NAC+RS group (37.5%) and IV-NAC+RS group (25.4%) were comparable (p > 0.05). (3) The intraoperative blood loss in the IA-NAC+RS group (average 92.13±84.09 mL) was significantly lower than that in the IV-NAC+RS group (average 127.2±82.36 mL) (p < 0.05). (4) The operation time of the IA-NAC+RS group (average 231.43±63.10 min) and the IV-NAC+RS group (average 219.82±49.11 min) were comparable (p > 0.05). (5) There were no significant differences between the IA-NAC+RS group and IV-NAC+RS group in pathological lymph node metastasis, parametrial invasion, and involvement of lymphovascular space (p > 0.05).Neoadjuvant chemotherapy combined with surgery had the same long-term survival benefit as concurrent chemoradiotherapy." @default.
• W4311579647 created "2022-12-27" @default.
• W4311579647 creator A5002938321 @default.
• W4311579647 creator A5034202632 @default.
• W4311579647 creator A5034814401 @default.
• W4311579647 creator A5035097771 @default.
• W4311579647 creator A5037960753 @default.
• W4311579647 creator A5043989533 @default.
• W4311579647 creator A5045846979 @default.
• W4311579647 creator A5065141144 @default.
• W4311579647 creator A5080967832 @default.
• W4311579647 creator A5085712319 @default.
• W4311579647 date "2022-12-07" @default.
• W4311579647 modified "2023-10-01" @default.
• W4311579647 title "The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation" @default.
• W4311579647 cites W192029542 @default.
• W4311579647 cites W1971657477 @default.
• W4311579647 cites W1972917232 @default.
• W4311579647 cites W1975039606 @default.
• W4311579647 cites W1997870754 @default.
• W4311579647 cites W2013978479 @default.
• W4311579647 cites W2032573380 @default.
• W4311579647 cites W2033616038 @default.
• W4311579647 cites W2051488343 @default.
• W4311579647 cites W2063946885 @default.
• W4311579647 cites W2082802514 @default.
• W4311579647 cites W2097945491 @default.
• W4311579647 cites W2106580179 @default.
• W4311579647 cites W2109701423 @default.
• W4311579647 cites W2130151943 @default.
• W4311579647 cites W2136159512 @default.
• W4311579647 cites W2142194495 @default.
• W4311579647 cites W2161714197 @default.
• W4311579647 cites W2167883466 @default.
• W4311579647 cites W2181816749 @default.
• W4311579647 cites W2199006423 @default.
• W4311579647 cites W2276423409 @default.
• W4311579647 cites W2292612401 @default.
• W4311579647 cites W2400050847 @default.
• W4311579647 cites W2402825826 @default.
• W4311579647 cites W2412208966 @default.
• W4311579647 cites W2566595793 @default.
• W4311579647 cites W2575552755 @default.
• W4311579647 cites W2737137651 @default.
• W4311579647 cites W2794056000 @default.
• W4311579647 cites W2802955457 @default.
• W4311579647 cites W2809927600 @default.
• W4311579647 cites W2889646458 @default.
• W4311579647 cites W2921444671 @default.
• W4311579647 cites W2991456413 @default.
• W4311579647 cites W3012358091 @default.
• W4311579647 cites W3119069170 @default.
• W4311579647 cites W3128646645 @default.
• W4311579647 cites W3165461539 @default.
• W4311579647 cites W4323873799 @default.
• W4311579647 doi "https://doi.org/10.1186/s12957-022-02859-w" @default.
• W4311579647 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36476481" @default.
• W4311579647 hasPublicationYear "2022" @default.
• W4311579647 type Work @default.
• W4311579647 citedByCount "0" @default.
• W4311579647 crossrefType "journal-article" @default.
• W4311579647 hasAuthorship W4311579647A5002938321 @default.
• W4311579647 hasAuthorship W4311579647A5034202632 @default.
• W4311579647 hasAuthorship W4311579647A5034814401 @default.
• W4311579647 hasAuthorship W4311579647A5035097771 @default.
• W4311579647 hasAuthorship W4311579647A5037960753 @default.
• W4311579647 hasAuthorship W4311579647A5043989533 @default.
• W4311579647 hasAuthorship W4311579647A5045846979 @default.
• W4311579647 hasAuthorship W4311579647A5065141144 @default.
• W4311579647 hasAuthorship W4311579647A5080967832 @default.
• W4311579647 hasAuthorship W4311579647A5085712319 @default.
• W4311579647 hasBestOaLocation W43115796471 @default.
• W4311579647 hasConcept C121608353 @default.
• W4311579647 hasConcept C126322002 @default.
• W4311579647 hasConcept C141071460 @default.
• W4311579647 hasConcept C143998085 @default.
• W4311579647 hasConcept C2776283816 @default.
• W4311579647 hasConcept C2776512503 @default.
• W4311579647 hasConcept C2776694085 @default.
• W4311579647 hasConcept C2778220009 @default.
• W4311579647 hasConcept C2778424827 @default.
• W4311579647 hasConcept C2780140570 @default.
• W4311579647 hasConcept C2781182431 @default.
• W4311579647 hasConcept C71924100 @default.
• W4311579647 hasConceptScore W4311579647C121608353 @default.
• W4311579647 hasConceptScore W4311579647C126322002 @default.
• W4311579647 hasConceptScore W4311579647C141071460 @default.
• W4311579647 hasConceptScore W4311579647C143998085 @default.
• W4311579647 hasConceptScore W4311579647C2776283816 @default.
• W4311579647 hasConceptScore W4311579647C2776512503 @default.
• W4311579647 hasConceptScore W4311579647C2776694085 @default.
• W4311579647 hasConceptScore W4311579647C2778220009 @default.
• W4311579647 hasConceptScore W4311579647C2778424827 @default.
• W4311579647 hasConceptScore W4311579647C2780140570 @default.
• W4311579647 hasConceptScore W4311579647C2781182431 @default.
• W4311579647 hasConceptScore W4311579647C71924100 @default.
• W4311579647 hasIssue "1" @default.
• W4311579647 hasLocation W43115796471 @default.
• W4311579647 hasLocation W43115796472 @default.
• W4311579647 hasLocation W43115796473 @default.

• next